Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer's disease mouse model

Molecules

Volumn 18, Issue 8, 2013, Pages 9949-9965

  Zhao, Le ^a   Wang, Jun Li ^a   Liu, Rui ^b   Li, Xiao Xu ^a   Li, Jian Fei ^a   Zhang, Lu ^a  

^a MINZU UNIVERSITY OF CHINA   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Alzheimer's disease; Amyloid peptide; Apigenin; Neurotrophin; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; APIGENIN; NERVE GROWTH FACTOR; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; GENETICS; METABOLISM; MOUSE; OXIDATIVE STRESS; PHYSIOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APIGENIN; MICE; MICE, TRANSGENIC; NERVE GROWTH FACTORS; OXIDATIVE STRESS; PRESENILIN-1;

EID: 84883178600     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18089949     Document Type: Article

References (55)

1. Selkoe, D.J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 1994, 17, 489-517.
2. Mattson, M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430, 631-639.
3. Chen, G.; Chen, K.S.; Knox, J.; Inglis, J.; Bernard, A.; Martin, S.J.; Justice, A.; McConlogue, L.; Games, D.; Freedman, S.B.; et al. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 2000, 408, 975-979.
4. Walsh, D.M.; Klyubin, I.; Fadeeva, J.V.; Cullen, W.K.; Anwyl, R.; Wolfe, M.S.; Rowan, M.J.; Selkoe, D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416, 535-539.
5. Anderson, A.J.; Su, J.H.; Cotman, C.W. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 1996, 16, 1710-1719.
6. Behl, C.; Davis, J.B.; Lesley, R.; Schubert, D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77, 817-827.
7. Busciglio, J.; Lorenzo, A.; Yeh, J.; Yankner, B.A. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995, 14, 879-888.
8. Lee, S.; Zemianek, J.; Shea, T.B. Rapid, Reversible impairment of synaptic signaling in cultured cortical neurons by exogenously-applied amyloid-β. J. Alzheimers Dis. 2013, 35, 395-402
9. Lue, L.F.; Kuo, Y.M.; Roher, A.E.; Brachova, L.; Shen, Y.; Sue, L.; Beach, T.; Kurth, J.H.; Rydel, R.E.; Rogers, J. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 1999, 155, 853-862.
10. Hou, Y.; Aboukhatwa, M.A.; Lei, D.L.; Manaye, K.; Khan, I.; Luo, Y. Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double Tg AD mice. Neuropharmacology 2010, 58, 911-920.
11. Tong, L.; Thornton, P.L.; Balazs, R.; Cotman, C.W. Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J. Biol. Chem. 2001, 276, 17301-17306.
12. Cotman, C.W. The role of neurotrophins in brain aging: a perspective in honor of Regino Perez-Polo. Neurochem. Res. 2005, 30, 877-881.
13. Liu, A.L.; Liu, B.; Qin, H.L.; Lee, S.M.; Wang, Y.T.; Du, G.H. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med. 2008, 74, 847-851.
14. Han, J.Y.; Ahn, S.Y.; Kim, C.S.; Yoo, S.K.; Kim, S.K.; Kim, H.C.; Hong, J.T.; Oh, K.W. Protection of apigenin against kainate-induced excitotoxicity by anti-oxidative effects. Biol. Pharm. Bull. 2012, 35, 1440-1446.
15. Markakis, E.A.; Palmer, T.D.; Randolph-Moore, L.; Rakic, P.; Gage, F.H. Novel neuronal phenotypes from neural progenitor cells. J. Neurosci. 2004, 24, 2886-2897.
16. Zhao, L.; Hou, L.; Sun, H.J.; Yan, X.; Sun, X.F.; Li, J.G.; Bian, Y.; Chu, Y.; Liu, Q.S. Apigenin isolated from the medicinal plant Elsholtzia rugulosa prevents β-amyloid 25-35-Induces toxicity in rat cerebral microvascular endothelial cells. Molecules 2011, 16, 4005-4019.
17. Liu, R.; Zhang, T.; Yang, H.; Lan, X.; Ying, J.; Du, G. The flavonoid apigenin protects brain neurovascular coupling against amyloid-beta25-35-induced toxicity in mice. J. Alzheimers Dis. 2011, 24, 85-100.
18. Ko, F.N; Huang, T.F.; Teng, C.M. Vasodilatory action mechanisms of apigenin isolated from Apium graveolens in rat thoracic aorta. Biochim. Biophys. Acta 1991, 1115, 69-74.
19. Losi, G.; Puia, G.; Garzon, G.; de Vuono, M.C.; Baraldi, M. Apigenin modulates GABAergic and glutamatergic transmission in cultured cortical neurons. Eur. J. Pharmacol. 2004, 502, 41-46.
20. Zhao, L.; Wang, J.L.; Wang, Y.R.; Fa, X.Z. Apigenin attenuates copper-mediated β-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model. Brain Res. 2013, 1492, 33-45.
21. Ono, K.; Yoshiike, Y.; Takashima, A.; Hasegawa, K.; Naiki, H.; Yamada, M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 2003, 7, 172-181.
22. Nitta, A.; Itoh, A.; Hasegawa, T.; Nabeshima, T. β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 1994, 170, 63-66.
23. Kar, S.; Issa, A.M.; Seto, D.; Auld, D.S.; Collier, B.; Quirion, R. Amyloid β-peptide inhibits highaffinity choline uptake and acetylcholine release in rat hippocampal slices. J. Neurochem. 1998, 70, 2179-2187.
24. Sigurdsson, E.M.; Lee, J.M.; Dong, X.W.; Hejna, M.J.; Lorens, S.A. Bilateral injections of amyloid-β 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects. Neurobiol. Aging. 1997, 18, 591-608.
25. Blanchard, V.; Moussaoui, S.; Czech, C.; Touchet, N.; Bonici, B.; Planche, M.; Canton, T.; Jedidi, I.; Gohin, M.; Wirths, O.; et al. Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp. Neurol. 2003, 184, 247-263.
26. Jankowsky, J.L.; Slunt, H.H.; Ratovitski, T.; Jenkins, N.A.; Copeland, N.G.; Borchelt, D.R. Co-expression of multiple transgenes in mouse CNS: A comparison of strategies. Biomol. Eng. 2001, 17, 157-165.
27. Trinchese, F.; Liu, S.; Battaglia, F.; Walter, S.; Mathews, P.M.; Arancio, O. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Ann. Neurol. 2004, 55, 801-814.
28. Patil, C.S.; Singh, V.P.; Satyanarayan, P.S.; Jain, N.K.; Singh, A.; Kulkarni, S.K. Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice. Pharmacology 2003, 69, 59-67.
29. Ding, Y.; Qiao, A.; Wang, Z.; Goodwin, J.S.; Lee, E.S.; Block, M.L.; Allsbrook, M.; McDonald, M.P.; Fan, G.H. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J. Neurosci. 2008, 28, 11622-11634.
30. Miners, J.S.; Morris, S.; Love, S.; Kehoe, P.G. Accumulation of insoluble amyloid-β in down's syndrome is associated with increased BACE-1 and neprilysin activities. J. Alzheimers Dis. 2011, 23, 101-108.
31. Amini, R.; Yazdanparast, R.; Bahramikia, S. Apigenin reduces human insulin fibrillation in vitro and protects SK-N-MC cells against insulin amyloids. Int. J. Biol. Macromol. 2013, 60C, 334-340.
32. Cole, S.L.; Vassar, R. The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. J. Biol. Chem. 2008, 283, 29621-29625.
33. Zhang, C.; Browne, A.; Divito, J.R.; Stevenson, J.A.; Romano, D.; Dong, Y.; Xie, Z.; Tanzi, R.E. Amyloid-beta production via cleavage of amyloid-beta protein precursor is modulated by cell density. J. Alzheimers Dis. 2010, 22, 683-984.
34. Shimmyo, Y.; Kihara, T.; Akaike, A.; Niidome, T.; Sugimoto, H. Flavonols and flavones as BACE-1 inhibitors: Structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochim. Biophys. Acta 2008, 1780, 819-825.
35. He, P.; Zhong, Z.; Lindholm, K.; Berning, L.; Lee, W.; Lemere, C.; Staufenbiel, M.; Li, R.; Shen, Y. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J. Cell Biol. 2007, 178, 829-841.
36. Rithidech, K.N.; Tungjai, M.; Reungpatthanaphong, P.; Honikel, L.; Simon, S.R. Attenuation of oxidative damage and inflammatory responses by apigenin given to mice after irradiation. Mutat. Res. 2012, 749, 29-38.
37. Wang, Y.C.; Huang, K.M. In vitro anti-inflammatory effect of apigenin in the Helicobacter pyloriinfected gastric adenocarcinoma cells. Food Chem. Toxicol. 2013, 53, 376-383.
38. Pratico, D.; Sung. S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J. Alzheimers Dis. 2004, 6, 171-175.
39. Pratico, D.; Uryu, K.; Leight, S.; Trojanoswki, J.Q.; Lee. V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 2001, 21, 4183-4187.
40. Lovell, M.A.; Ehmann, W.D.; Butler, S.M.; Markesbery, W.R. Elevated thiobarbituric acidreactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 1995, 45, 1594-1601.
41. Smith, M.A.; Perry, G.; Richey, P.L.; Sayre, L.M.; Anderson, V.E.; Beal, M.F.; Kowall, N. Oxidative damage in Alzheimer's. Nature 1996, 382, 120-121.
42. Markesbery, W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biol. Med. 1997, 23, 134-147.
43. Park, L.; Anrather, J.; Zhou, P.; Frys, K.; Pitstick, R.; Younkin, S.; Carlson, G.A.; Iadecola, C. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J. Neurosci. 2005, 25, 1769-1777.
44. Wang, C.N.; Chi, C.W.; Lin, Y.L.; Chen, C.F.; Shiao, Y.J. The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J. Biol. Chem. 2001, 276, 5287-5295.
45. Lin, C.M.; Chen, C.T.; Lee, H.H.; Lin, J.K. Prevention of cellular ROS damage by isovitexin and related flavonoids. Planta Med. 2002, 68, 365-367.
46. Ozyürek, M.; Bektaşoǧlu, B.; Güçlü, K.; Apak, R. Measurement of xanthine oxidase inhibition activity of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method. Anal. Chim. Acta 2009, 636, 42-50.
47. Liu, R.; Zhang, T.T.; Zhou, D.; Bai, X.Y.; Zhou, W.L.; Huang, C.; Song, J.K.; Meng, F.R.; Wu, C.X.; Li, L.; et al. Quercetin protects against the Aβ(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU. Neuropharmacology 2013, 67, 419-431.
48. Carew, T.J. Molecular enhancement of memory formation. Neuron 1996, 16, 5-8.
49. Barco, A.; Pittenger, C.; Kandel, E.R. CREB, Memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects. Expert Opin. Ther. Targets 2003, 7, 101-114.
50. Pham, T.A.; Impey, S.; Storm, D.R.; Stryker, M.P. CRE-mediated gene transcription in neocortical neuronal plasticity during the developmental critical period. Neuron 1999, 22, 63-72.
51. Bekinschtein, P.; Cammarota, M.; Igaz, L.M.; Bevilaqua, L.R.; Izquierdo, I.; Medina, J.H. Persistence of long-term memory storage requires a late protein synthesis- and BDNF-dependent phase in the hippocampus. Neuron 2007, 53, 261-277.
52. Heldt, S.A.; Stanek, L.; Chhatwal, J.P.; Ressler, K.J. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol. Psychiatry 2007, 12, 656-670.
53. Tyler, W.J.; Alonso, M.; Bramham, C.R.; Pozzo-Miller, L.D. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem. 2002, 9, 224-237.
54. Tong, L.; Balazs, R.; Thornton, P.L.; Cotman, C.W. Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J. Neurosci. 2004, 24, 6799-6809.
55. Peng, Y.; Hu, Y.; Xu, S.; Li, P.; Li, J.; Lu, L.; Yang, H.; Feng, N.; Wang, L.; Wang, X. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AßPP/PS1-Alzheimers transgenic mice. J. Alzheimers Dis. 2012, 29, 379-391.